1 – 20 of 65
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity
(
- Contribution to journal › Article
-
Mark
CT-based volumetric measures obtained through deep learning : Association with biomarkers of neurodegeneration
(
- Contribution to journal › Article
-
Mark
Novel avenues of tau research
(
- Contribution to journal › Scientific review
-
Mark
Clinical recognition of frontotemporal dementia with right anterior temporal predominance : A multicenter retrospective cohort study
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
-
Mark
Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum
(
- Contribution to journal › Article
-
Mark
Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
(
- Contribution to journal › Article
-
Mark
In vivo detection of Alzheimer's and Lewy body disease concurrence : Clinical implications and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
(
- Contribution to journal › Article
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
(
- Contribution to journal › Article
-
Mark
Structural white matter properties and cognitive resilience to tau pathology
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
- 2023
-
Mark
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models
(
- Contribution to journal › Article
-
Mark
European consensus for the diagnosis of MCI and mild dementia : Preparatory phase
(
- Contribution to journal › Article
-
Mark
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients
(
- Contribution to journal › Article
-
Mark
Associations between dietary patterns and dementia-related neuroimaging markers
(
- Contribution to journal › Article
-
Mark
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients : A multi-cohort study
(
- Contribution to journal › Article
-
Mark
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population : The ABIDE project
(
- Contribution to journal › Article
-
Mark
Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Sex differences in associations between APOE ε2 and longitudinal cognitive decline
(
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
(
- Contribution to journal › Article